Surface Oncology - 1 Year Stock Price History | SURF
Historical daily share price chart and data for Surface Oncology since 2018 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Surface Oncology as of January 18, 2019 is 4.91.
|Surface Oncology Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical Products Manufacturing
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.